Lisa de Jong - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Lisa de Jong

This paper is made freely available by the publisher.

2023 Robbert Bakema

ORCID

, Daria Smirnova

ORCID

ORCID

, Janwillem W. H. Kocks

ORCID

, Maarten J. Postma

ORCID

, Lisa A. de Jong

ORCID

The Use of eHealth for Pharmacotherapy Management With Patients With Respiratory Disease, Cardiovascular Disease, or Diabetes: Scoping Review

Download from doi.org

This paper is made freely available by the publisher.

Tanja Fens

ORCID

, Lisa de Jong

ORCID

, Bregt Kappelhoff

ORCID

, Cornelis Boersma

ORCID

, Maarten J. Postma

ORCID

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran

Download from doi.org

This paper is made freely available by the publisher.

2020 Lisa A. de Jong

ORCID

, Annette W. G. van der Velden, Marinus van Hulst, Maarten J. Postma

Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism

Download from doi.org

This paper is made freely available by the publisher.

2019 Lisa A. de Jong

ORCID

, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G. Tieleman, Menno V. Huisman, Maarten J. Postma, Marinus van Hulst

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Lisa Aniek de Jong

ORCID

, Judith J. Gout-Zwart, Marina van den Bosch, Mike Koops, Maarten J. Postma

ORCID

Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis

Upload

This paper is made freely available by the publisher.

2017 Maartje S. Jacobs

ORCID

, Lisa A. de Jong

ORCID

, Maarten J. Postma, Robert G. Tieleman, Marinus van Hulst

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2016 L. De Jong

ORCID

, Lisa A. de Jong, Ep Dvortsin, Kj Janssen, Mj Postma

Cost-Effectiveness Analysis for Apixaban in The Acute Treatment and Prevention of Venous Thromboembolism in The Netherlands

Upload

This paper is made freely available by the publisher.

J. Stevanović, L. A. de Jong

ORCID

, B. S. Kappelhoff, E. P. Dvortsin, M. Voorhaar, M. J. Postma

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

Download from doi.org

Missing publications? Search for publications with a matching author name.